STM Journals Peer-reviewed research from Consortium e-Learning Network

Research and Reviews: A Journal of Toxicology Review Article

Overview of Diabetic Neuropathy: A Comprehensive Examination

  1. Gyanendra Kumar Gupta
  2. Gagan Devi

Abstract

Abstract: India has earned the unfortunate distinction of being the global epicenter for diabetes, with an alarming projection of 109 million individuals expected to be afflicted by the condition by 2035The global influence of diabetic neuropathy is significant, with an estimated 132 million individuals affected as of 2010, constituting roughly 1.9% of the global populace. Notably, within the diabetic population, there exists a significantly heightened prevalence The prevalence of sensory peripheral neuropathy stands at 60.4%, with an incidence rate of 8.76%. trend is particularly concerning as individuals age, with the likelihood of neuropathy increasing over time.The pervasive nature of this disease extends beyond national borders, presenting a burgeoning global challenge that profoundly influences daily life. The repercussions of diabetic neuropathy are multifaceted, encompassing sensory impairments, motor dysfunction, and an array of complications that compromise overall well-being. Tasks as seemingly mundane as walking, grasping objects, or even maintaining balance become formidable challenges for those affected. Moreover, the socioeconomic ramifications of diabetic neuropathy are substantial, as individuals contend with reduced productivity, increased healthcare expenditures, and diminished quality of life. Furthermore, the burden extends to caregivers and healthcare systems, amplifying the strain on resources and exacerbating healthcare disparities. Essentially, the widespread and increasing occurrence of diabetic neuropathy emphasizes the critical necessity for comprehensive approaches focused on preventing, detecting early, and managing it effectively. Addressing this multifaceted challenge demands a concerted global effort, encompassing research, policy initiatives, public awareness campaigns, and accessible 2 healthcare services. Only through collective action can we hope to mitigate the profound impact of this global health crisis and alleviate the suffering endured by millions worldwide 2 healthcare services. Only through collective action can we hope to mitigate the profound impact of this global health crisis and alleviate the suffering endured

Keywords

References (48)

  1. Goldmamn’scecil medicine 24 th ed. By Saunders ,an imprint of Elsevier Copyright,2012
  2. edited by Lee Goldman and Andrew I Schafer.
  3. Indian Heart Association why south asians facts Web. 30 April 2015.
  4. http://indianheartassociation.org/why-indians-why-south-asians/overview
  5. Vos, T (Dec 15, 2012). "Years lived with disability (ylds) for 1160 sequelae of 289 diseases
  6. and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010."
  7. Lancet 380 (9859): 2163–96.
  8. Battula P et al. International Journal of Research in Medical Sciences Int J Res Med Sci.
  9. 2017 Sep;5(9):4066-4071)
  10. http://www.ncbi.nlm.nih.gov/pubmed/21274758
  11. Pandit Hari Sadasiva Sastri Paradakara editor, Ashtanga Hridaya with the
  12. commentaries Sarvangasundara of Arundatta and Ayurveda Rasayana of Hemadri,
  13. Bhisagacarya; Nidansthan, Chapter 10, Verse 22, Chaukhamba Orientalia, Varanasi,
  14. Reprint -2000, pg 321
  15. Aacharya Vaidya Jadavaji Trikamji., editor. Agnivesha, Charaka, Charaka samhita,
  16. Nidana Sthana, Adhyaya. Varanasi: Chaukhamba Sanskrit sansthan. 2nd ed. 47.
  17. Vol. 4. Dridhabala. Varanasi: Chaukhamba Sanskrit sansthan; 1990. 325.
  18. 8Taber’s cyclopedic medical dictionary, 20 th edition, f.a.davis company, pg.no. 1462
  19. Zeng L, Alongkronrusmee D, van Rijn RM. An integrated perspective on diabetic,
  20. alcoholic, and drug-induced neuropathy, etiology, and treatment in the US. J Pain Res. 2017
  21. Indian Heart Association why south asians facts Web. 30 April
  22. http://indianheartassociation.org/why-indians-why-south-asians/overview
  23. Vos, T (Dec 15, 2012). "Years lived with disability (ylds) for 1160 sequelae of 289
  24. diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease
  25. Study 2010." Lancet 380 (9859): 2163–96.
  26. International Journal of Research in Medical Sciences Battula P et al. Int J Res Med Sci.
  27. 2017 Sep;5(9):4066-4071
  28. https://emedicine.medscape.com/article/1170337
  29. Dorsey RR, Eberhardt MS, Gregg EW, Geiss LS. Control of risk factors among people
  30. with diagnosed diabetes, by lower extremity disease status. Prev Chronic Dis. 2009 Oct.
  31. Tavakkoly-Bazzaz J, Amoli MM, Pravica V, Chandrasecaran R, Boulton AJ, Larijani B.
  32. VEGF gene polymorphism association with diabetic neuropathy. Mol Biol Rep. 2010 Mar
  33. Diabetes control and complications trial research group. The effect of intensive treatment
  34. of diabetes on the development and progression of long-term complications in insulin-
  35. dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group.
  36. N Engl J Med. 1993 Sep 30. 329(14):977-86
  37. Harati Y. Diabetes and the nervous system. Endocrinal Metab Clin North Am. 1996 Jun.
  38. 25(2):325-59.
  39. Rutkove SB. A 52-year-old woman with disabling peripheral neuropathy: review of
  40. diabetic polyneuropathy. JAMA. 2009 Oct 7. 302(13):1451-8.
  41. Jende JME, Groener JB, Oikonomou D, et al. Diabetic neuropathy differs between type 1
  42. and type 2 diabetes Insights from magnetic resonance neurography. Ann Neurol. 2018 Feb
  43. Ryle C, Donaghy M. Non-enzymatic glycation of peripheral nerve proteins in human
  44. diabetics. J Neurol Sci. 1995 Mar. 129(1):62-8
  45. Figueroa-Romero C, Sadidi M, Feldman EL. Mechanisms of disease: The oxidative stress
  46. theory of diabetic neuropathy. Rev Endocr Metab Disord. 2008 Dec. 9(4):301-14
  47. American Diabetes Association. Standards of Medical Care in Diabetes—2009. Diabetes
  48. Care. 2009;32:S13-61
Support